Luther King Capital Management (LKCM)’s Idexx Laboratories IDXX Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Hold	4,725	–	–	0.01%	339
2026 Q1	$2.65M	Buy	4,725 +24	+0.5%	+$15.4K	0.01%	325
2025 Q4	$3.18M	Sell	4,701 -5	-0.1%	-$3.4K	0.01%	304
2025 Q3	$3.01M	Hold	4,706	–	–	0.01%	301
2025 Q2	$2.52M	Sell	4,706 -190	-4%	-$90.9K	0.01%	308
2025 Q1	$2.06M	Buy	4,896 +24	+0.5%	+$10.4K	0.01%	316
2024 Q4	$2.01M	Buy	4,872 +175	+4%	+$76.8K	0.01%	323
2024 Q3	$2.37M	Sell	4,697 -14	-0.3%	-$6.8K	0.01%	303
2024 Q2	$2.3M	Sell	4,711 -82	-2%	-$41.2K	0.01%	297
2024 Q1	$2.59M	Sell	4,793 -58	-1%	-$31.7K	0.01%	297
2023 Q4	$2.69M	Hold	4,851	–	–	0.01%	286
2023 Q3	$2.12M	Sell	4,851 -10	-0.2%	-$4.99K	0.01%	311
2023 Q2	$2.44M	Sell	4,861 -4	-0.1%	-$1.92K	0.01%	298
2023 Q1	$2.43M	Sell	4,865 -42	-0.9%	-$20.1K	0.01%	286
2022 Q4	$2M	Buy	4,907 +100	+2%	+$38.8K	0.01%	302
2022 Q3	$1.57M	Buy	4,807 +9	+0.2%	+$3.31K	0.01%	309
2022 Q2	$1.68M	Buy	4,798 +596	+14%	+$243K	0.01%	319
2022 Q1	$2.3M	Sell	4,202 -22	-0.5%	-$11.6K	0.01%	293
2021 Q4	$2.78M	Hold	4,224	–	–	0.01%	276
2021 Q3	$2.63M	Hold	4,224	–	–	0.01%	274
2021 Q2	$2.67M	Hold	4,224	–	–	0.01%	287
2021 Q1	$2.07M	Buy	4,224 +10	+0.2%	+$5.01K	0.01%	295
2020 Q4	$2.11M	Sell	4,214 -50	-1%	-$22.4K	0.01%	278
2020 Q3	$1.68M	Hold	4,264	–	–	0.01%	275
2020 Q2	$1.41M	Hold	4,264	–	–	0.01%	282
2020 Q1	$1.03M	Buy	+4,264	New	+$1.11M	0.01%	297
2019 Q4	–	Sell	-4,444	Closed	-$1.21M	–	556
2019 Q3	$1.21M	Hold	4,444	–	–	0.01%	328
2019 Q2	$1.22M	Buy	4,444 +278	+7%	+$68.5K	0.01%	321
2019 Q1	$932K	Sell	4,166 -6	-0.1%	-$1.24K	0.01%	355
2018 Q4	$776K	Buy	4,172 +6	+0.1%	+$1.23K	0.01%	359
2018 Q3	$1.04M	Sell	4,166 -82	-2%	-$19.9K	0.01%	363
2018 Q2	$926K	Sell	4,248 -100	-2%	-$20.6K	0.01%	357
2018 Q1	$832K	Hold	4,348	–	–	0.01%	371
2017 Q4	$680K	Hold	4,348	–	–	0.01%	395
2017 Q3	$676K	Sell	4,348 -122	-3%	-$19.3K	0.01%	384
2017 Q2	$722K	Hold	4,470	–	–	0.01%	374
2017 Q1	$691K	Hold	4,470	–	–	0.01%	382
2016 Q4	$524K	Hold	4,470	–	–	0.01%	401
2016 Q3	$504K	Sell	4,470 -200	-4%	-$21.1K	﹤0.01%	396
2016 Q2	$434K	Sell	4,670 -230	-5%	-$19.8K	﹤0.01%	411
2016 Q1	$384K	Hold	4,900	–	–	﹤0.01%	423
2015 Q4	$357K	Buy	4,900 +878	+22%	+$62.6K	﹤0.01%	446
2015 Q3	$299K	Buy	4,022 +22	+0.6%	+$1.58K	﹤0.01%	461
2015 Q2	$257K	Sell	4,000 -3,804	-49%	-$263K	﹤0.01%	496
2015 Q1	$603K	Sell	7,804 -1,000	-11%	-$77.8K	0.01%	410
2014 Q4	$653K	Hold	8,804	–	–	0.01%	412
2014 Q3	$519K	Hold	8,804	–	–	﹤0.01%	452
2014 Q2	$588K	Buy	8,804 +4,400	+100%	+$280K	﹤0.01%	439
2014 Q1	$267K	Sell	4,404 -1,600	-27%	-$95.3K	﹤0.01%	488
2013 Q4	$319K	Sell	6,004 -3,480	-37%	-$183K	﹤0.01%	469
2013 Q3	$473K	Hold	9,484	–	–	﹤0.01%	546
2013 Q2	$425K	Buy	+9,484	New	+$414K	﹤0.01%	560

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Luther King Capital Management (LKCM)'s IDXX Position: Q2 2026 in Review

Luther King Capital Management (LKCM) held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 4,725 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #339.

Luther King Capital Management (LKCM) first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.18M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Luther King Capital Management (LKCM) held 4,725 shares of Idexx Laboratories worth $2.49M as of Q2 2026.
Luther King Capital Management (LKCM) left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #339 holding.
Luther King Capital Management (LKCM) first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
Luther King Capital Management (LKCM)'s Idexx Laboratories position peaked at $3.18M in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.